Linus Backert
Linus Backert
Verified email at
Cited by
Cited by
Immunoinformatics and epitope prediction in the age of genomic medicine
L Backert, O Kohlbacher
Genome medicine 7 (1), 1-12, 2015
Safety and immunogenicity of a mRNA rabies vaccine in healthy adults: an open-label, non-randomised, prospective, first-in-human phase 1 clinical trial
M Alberer, U Gnad-Vogt, HS Hong, KT Mehr, L Backert, G Finak, ...
The Lancet 390 (10101), 1511-1520, 2017
HLA ligandome analysis identifies the underlying specificities of spontaneous antileukemia immune responses in chronic lymphocytic leukemia (CLL)
DJ Kowalewski, H Schuster, L Backert, C Berlin, S Kahn, L Kanz, ...
Proceedings of the National Academy of Sciences 112 (2), E166-E175, 2015
The immunopeptidomic landscape of ovarian carcinomas
H Schuster, JK Peper, HC Bösmüller, K Röhle, L Backert, T Bilich, B Ney, ...
Proceedings of the National Academy of Sciences 114 (46), E9942-E9951, 2017
The antigenic landscape of multiple myeloma: mass spectrometry (re) defines targets for T-cell–based immunotherapy
S Walz, JS Stickel, DJ Kowalewski, H Schuster, K Weisel, L Backert, ...
Blood, The Journal of the American Society of Hematology 126 (10), 1203-1213, 2015
Unveiling the peptide motifs of HLA-C and HLA-G from naturally presented peptides and generation of binding prediction matrices
M Di Marco, H Schuster, L Backert, M Ghosh, HG Rammensee, ...
The Journal of Immunology 199 (8), 2639-2651, 2017
AureoWiki ̵ The repository of the Staphylococcus aureus research and annotation community
S Fuchs, H Mehlan, J Bernhardt, A Hennig, S Michalik, K Surmann, ...
International Journal of Medical Microbiology 308 (6), 558-568, 2018
Mapping the HLA ligandome of colorectal cancer reveals an imprint of malignant cell transformation
MW Löffler, DJ Kowalewski, L Backert, J Bernhardt, P Adam, H Schuster, ...
Cancer research 78 (16), 4627-4641, 2018
HLA ligandome analysis of primary chronic lymphocytic leukemia (CLL) cells under lenalidomide treatment confirms the suitability of lenalidomide for combination with T-cell …
A Nelde, DJ Kowalewski, L Backert, H Schuster, JO Werner, R Klein, ...
Oncoimmunology 7 (4), e1316438, 2018
The natural HLA ligandome of glioblastoma stem-like cells: antigen discovery for T cell-based immunotherapy
MC Neidert, DJ Kowalewski, M Silginer, K Kapolou, L Backert, ...
Acta neuropathologica 135 (6), 923-938, 2018
Characterization of the canine MHC class I DLA-88* 50101 peptide binding motif as a prerequisite for canine T cell immunotherapy
SM Barth, CM Schreitmüller, F Proehl, K Oehl, LM Lumpp, DJ Kowalewski, ...
PLoS One 11 (11), e0167017, 2016
A new synthetic toll-like receptor 1/2 ligand is an efficient adjuvant for peptide vaccination in a human volunteer
HG Rammensee, KH Wiesmüller, PA Chandran, H Zelba, E Rusch, ...
Journal for immunotherapy of cancer 7 (1), 1-18, 2019
Carfilzomib alters the HLA-presented peptidome of myeloma cells and impairs presentation of peptides with aromatic C-termini
DJ Kowalewski, S Walz, L Backert, H Schuster, O Kohlbacher, K Weisel, ...
Blood cancer journal 6 (4), e411-e411, 2016
The HLA Ligand Atlas: A novel immuno-oncology resource for T-cell antigen discovery.
A Marcu, L Bichmann, L Kuchenbecker, L Backert, DJ Kowalewski, ...
Journal of Clinical Oncology 38 (15_suppl), 3128-3128, 2020
Haploidentical hematopoietic cell transplantation using in vitro T cell depleted grafts as salvage therapy in patients with disease relapse after prior allogeneic transplantation
SP Haen, C Groh, M Schumm, L Backert, MW Löffler, B Federmann, ...
Annals of hematology 96 (5), 817-827, 2017
Distinct transcriptional changes in non-small cell lung cancer patients associated with multi-antigenic RNActive® CV9201 immunotherapy
HS Hong, SD Koch, B Scheel, U Gnad-Vogt, A Schröder, KJ Kallen, ...
Oncoimmunology 5 (12), e1249560, 2016
A meta-analysis of HLA peptidome composition in different hematological entities: entity-specific dividing lines and “pan-leukemia” antigens
L Backert, DJ Kowalewski, S Walz, H Schuster, C Berlin, MC Neidert, ...
Oncotarget 8 (27), 43915, 2017
ToxDBScan: large-scale similarity screening of toxicological databases for drug candidates
M Römer, L Backert, J Eichner, A Zell
International journal of molecular sciences 15 (10), 19037-19055, 2014
Integrative-omics and HLA-ligandomics analysis to identify novel drug targets for ccRCC immunotherapy
A Reustle, M Di Marco, C Meyerhoff, A Nelde, JS Walz, S Winter, ...
Genome medicine 12, 1-24, 2020
Favorable immune signature in CLL patients, defined by antigen-specific T-cell responses, might prevent second skin cancers
JS Walz, DJ Kowalewski, L Backert, A Nelde, O Kohlbacher, B Weide, ...
Leukemia & lymphoma 59 (8), 1949-1958, 2018
The system can't perform the operation now. Try again later.
Articles 1–20